MyFinsight
Home
Blog
About
Short-term investments
$112,907K
(-47.66%↓ Y/Y)
Cash and cash
equivalents
$112,485K
(91.26%↑ Y/Y)
Prepaid expenses and
other current assets
$3,521K
(-21.18%↓ Y/Y)
Total current assets
$228,913K
(-17.95%↓ Y/Y)
Property and equipment,
net
$11,734K
(-17.65%↓ Y/Y)
Operating lease
right-of-use assets
$2,263K
(-13.00%↓ Y/Y)
Other non-current
assets
$1,107K
(1.00%↑ Y/Y)
Restricted cash
$339K
(0.00%↑ Y/Y)
Finance lease
right-of-use assets
$8K
(-82.22%↓ Y/Y)
Total assets
$244,364K
(-17.81%↓ Y/Y)
Total liabilities and
stockholders' equity
$244,364K
(-17.81%↓ Y/Y)
Total stockholders'
equity
$217,133K
(-20.54%↓ Y/Y)
Total liabilities
$27,231K
(13.17%↑ Y/Y)
Accumulated deficit
-$418,071K
(-36.20%↓ Y/Y)
Additional paid-in capital
$635,204K
(9.48%↑ Y/Y)
Total current
liabilities
$21,505K
(39.28%↑ Y/Y)
Operating lease
liabilities, non-current
$5,316K
(-32.05%↓ Y/Y)
Contingent value rights
liability, non-current
$407K
(-44.85%↓ Y/Y)
Finance lease
liabilities, non-current
$3K
(-66.67%↓ Y/Y)
Accrued expenses and
other current...
$15,185K
(66.92%↑ Y/Y)
Accounts payable
$3,294K
(59.90%↑ Y/Y)
Operating lease
liabilities, current
$3,021K
(-2.30%↓ Y/Y)
Finance lease
liabilities, current
$5K
(-88.10%↓ Y/Y)
Back
Back
Balance Sheet
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)
source: myfinsight.com